Due to the limited amount of bone that can be harvested from an individual and to surgical complications of
harvesting bone, the medical and dental community like San Francisco dentist

Mohamed Ali, turn to the tissue banks as sources for bone grafting materials.

How did Autogenous Bone Graft come into practice?

There are two kinds of bone available: the allograft bone, which is harvested from very well screened
cadavers, and the xenograftt material, which is harvested from animals. Despite

the extreme safety of the allograft and xenograft materials, some patients

remained reluctant to using these materials for themselves.

When was Autogenous Bone Graft first used?

Further research revealed a new approach to obtaining additional bone. In March 2007, the FDA approved the
use of Infuse Bone Graft

(rhBMP-2) in dentistry as an alternative to autogenous bone graft.

How the Autogenous Bone Graft developed?

Infuse Bone Graft is recombinant human bone morphogenetic protein. The way Infuse Bone Graft works
is by inducing the patient’s own response in the surgical sites to transform

stem cells into bone cells.

Infuse Bone Graft material is a big leap in the surgical approach to developing the bone site for dental
implants. For Mohamed Ali San Francisco dental surgery, it has made autogenous bone grafting more predictable

with fewer complications and less trauma to all patients.